4.2 Article

Safety and effectiveness of a 300 IR house dust mite sublingual tablet: descriptive 4-year final analysis of a post-marketing surveillance in Japan

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Review Allergy

Executive summary: Japanese guidelines for allergic rhinitis 2020

Mitsuhiro Okano et al.

Summary: The Practical Guideline for the Management of Allergic Rhinitis, the first guideline for allergic rhinitis in Japan, was prepared in 1993 and the current 9th edition was published in 2020. It incorporates evidence-based medicine and includes updated epidemiology, mechanisms, assessment, pharmacotherapy, immunotherapy, surgical classification, treatment, and prescriptions for older adults. The guideline also provides an evidence-based step-by-step treatment strategy.

ALLERGOLOGY INTERNATIONAL (2023)

Article Allergy

Coordinated IgG2 and IgE responses as a marker of allergen immunotherapy efficacy

Veronique Bordas-Le Floch et al.

Summary: This study found that after house dust mite immunotherapy, there is a significant increase in HDM-specific serum IgG2 responses among high responders. Subjects benefiting the most from HDM-AIT show a higher correlation between HDM-specific IgG2, IgE, and/or IgG4 responses, which may help differentiate between high and low responders.

ALLERGY (2022)

Article Allergy

The SQ HDM SLIT-Tablet is safe and well tolerated in patients with House Dust Mite allergic rhinitis with or without asthma: A real-life French study

Pascal Demoly et al.

Summary: This study evaluated the safety of the SQ House Dust Mite SubLingual ImmunoTherapy (SLIT)-Tablet in patients with allergic rhinitis and allergic asthma under real-life conditions. The results indicated a good safety profile for the medication, regardless of asthma control.

CLINICAL AND TRANSLATIONAL ALLERGY (2022)

Article Allergy

A 300 IR sublingual tablet is an effective, safe treatment for house dust mite?induced allergic rhinitis: An international, double-blind, placebo-controlled, randomized phase III clinical trial

Pascal Demoly et al.

Summary: The study evaluated the efficacy and safety of a 300 index of reactivity sublingual tablet for allergic rhinitis induced by house dust mites, showing significant improvement in symptoms and good tolerability. This treatment is proven to be effective and safe for patients with moderate to severe allergic rhinitis.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2021)

Article Immunology

Safety and effectiveness of the 300 IR sublingual house dust mite allergen immunotherapy tablet: 2-year interim analysis of a specified drug-use survey

Yoshitaka Okamoto et al.

Summary: The study conducted a postmarketing drug-use survey on registered outpatients and found that the house dust mite sublingual tablet demonstrated good safety and effectiveness in real-world conditions after 2 years of continuous use, significantly improving the severity score of rhinitis.

IMMUNOTHERAPY (2021)

Article Allergy

Mechanisms of Subcutaneous and updates Sublingual Aeroallergen Immunotherapy: What Is New?

Zsolt Istvan Komlosi et al.

IMMUNOLOGY AND ALLERGY CLINICS OF NORTH AMERICA (2020)

Review Allergy

Japanese guidelines for allergic rhinitis 2020

Kimihiro Okubo et al.

ALLERGOLOGY INTERNATIONAL (2020)

Review Allergy

Mechanisms of allergen-specific immunotherapy and allergen tolerance

Umut C. Kucuksezer et al.

ALLERGOLOGY INTERNATIONAL (2020)

Article Medicine, General & Internal

Allergic rhinitis

Jean Bousquet et al.

NATURE REVIEWS DISEASE PRIMERS (2020)

Review Allergy

Duration of allergen immunotherapy for inhalant allergy

Martin Penagos et al.

CURRENT OPINION IN ALLERGY AND CLINICAL IMMUNOLOGY (2019)

Article Allergy

Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study

Enrica Menditto et al.

CLINICAL AND EXPERIMENTAL ALLERGY (2019)

Article Allergy

Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines-2016 revision

Jan L. Brozek et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Article Allergy

Mechanisms of allergen immunotherapy for inhaled allergens and predictive biomarkers

Mohamed H. Shamji et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2017)

Article Allergy

Respiratory allergy caused by house dust mites: What do we really know?

Moises A. Calderon et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)

Article Allergy

Efficacy and safety of sublingual tablets of house dust mite allergen extracts in adults with allergic rhinitis

Karl-Christian Bergmann et al.

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2014)

Review Allergy

Japanese Guideline for Allergic Rhinitis 2014

Kimihiro Okubo et al.

ALLERGOLOGY INTERNATIONAL (2014)